In conclusion, to the best of our knowledge, this is the first study to analyze the effects of c.309T>G in the MDM2 gene together with p53 Arg72Pro as well as mutations in the EGFR. KRAS and p53 genes on the prognoses of lung cancer patients. Here, KRAS is linked to lung carcinoma.